Showing results (3261-3270 of 3,696) with videos related to
Sort By:
Pageof 370
Contemporary Clinical Trials|July 23, 2008
Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX libraryKenneth W Mahaffey, Craig J Reist, Yuling Fu, et al.Contemporary Clinical Trials|June 21, 2008
Usefulness of a run-in period to reduce drop-outs in a randomized controlled trial of a behavioral interventionMichelle Ulmer, Donald Robinaugh, Jennifer P Friedberg, et al.Contemporary Clinical Trials|June 13, 2006
An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: rationale and designGbenga Ogedegbe, Antoinette Schoenthaler, Tabia Richardson, et al.Contemporary Clinical Trials|April 17, 2007
Industry-sponsored research in developing countriesE E AbbasContemporary Clinical Trials|October 13, 2006
Screening for Auditory Impairment-Which Hearing Assessment Test (SAI-WHAT): RCT design and baseline characteristicsBevan Yueh, Margaret P Collins, Pamela E Souza, et al.Contemporary Clinical Trials|October 13, 2006
Value of recruitment strategies used in a primary care practice-based trialShellie D Ellis, Alain G Bertoni, Denise E Bonds, et al.Contemporary Clinical Trials|October 13, 2006
Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitusRonald P Stolk, Johannes R Vingerling, J Kennedy Cruickshank, et al.Contemporary Clinical Trials|October 3, 2006
The effect of omitted covariates on confidence interval and study power in binary outcome analysis: a simulation studyAbdissa Negassa, James A HanleyContemporary Clinical Trials|August 9, 2007
Accounting for the sedative and analgesic effects of medication changes during patient participation in clinical research studies: measurement development and application to a sample of institutionalized geriatric patientsPhilip Sloane, Jena Ivey, Mary Roth, et al.Contemporary Clinical Trials|June 19, 2007
Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trialNeil Fleshner, Leonard G Gomella, Michael S Cookson, et al.Pageof 370